Skip to content
lifestyle.thriveinsider.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Nanobiotix S.A.
NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results
April 1, 2026
NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
March 30, 2026
NANOBIOTIX Statement Regarding Recent Media Speculation
March 25, 2026
Voting Rights and Shares Capital of the Company
February 17, 2026
←
Previous Page
1
2
3